| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |